Pediatric Zestril
Executive Summary
FDA approves AstraZeneca's ACE-inhibitor Zestril (lisinopril) July 1 for treatment of hypertension in children six to 16. AstraZeneca licenses the compound from Merck. The two companies had pediatric exclusivity for lisinopril products through June 29, 2002 (1"The Pink Sheet" Dec. 3, 2001, In Brief)...